Background: Clinicians currently rely on patientdesignated and next-of-kin surrogates to make end-oflife treatment decisions for incapacitated patients. Surrogates are instructed to use the substituted judgment standard, which directs them to make the treatment decision that the patient would have made if he or she were capacitated. However, commentators have questioned the accuracy with which surrogates predict patients' treatment preferences.
C
LINICAL PRACTICE EMPHAsizes the importance of allowing patients to make their own medical decisions. This approach allows individuals to determine the course of their medical care, thereby respecting patient autonomy. However, this approach also raises concern about how clinicians should make treatment decisions for patients who lack the functional capacity to make their own decisions.
Clinicians currently rely on patientdesignated and next-of-kin surrogates to make treatment decisions for incapacitated patients. The Patient Self-Determination Act guarantees patients the right to formally designate a surrogate to make treatment decisions for them if they become unable to make their own decisions. 1 When patients lose the capacity to make their own decisions and have not designated a surrogate, most states have statutes to identify a nextof-kin surrogate for them. 2 Patient-designated and next-of-kin surrogates are instructed to make decisions based on the substituted judgment standard, which involves making the treatment decision that the patient would have made if he or she were capacitated. 3 Surrogates should use the best interests standard, which directs them to make decisions based on what is in the patient's best interests, but only when they lack sufficient evidence to determine what decision the patient would have made.
Use of the substituted judgment standard is typically defended on the grounds that it extendspatientautonomy,allowingthepreferences and values of the patients to guide theirmedicalcareevenaftertheylosetheability to make their own treatment decisions. 4 In practice, reliance on surrogates offers an effective way to implement the substituted judgmentstandardonlyifpatient-designated or next-of-kin surrogates can accurately predictwhatdecisionspatientswouldhavemade if they were capacitated. Yet, commentators argue that surrogates are "frequently inaccurate," 5 disagree at "a striking rate" with patient preferences, 6 and are "not better than chance" at predicting the decisions patients would have made if they were capacitated. 7 Wethereforesystematicallyanalyzed the existing empirical literature on surrogate accuracy to determine how well surrogates predict patients' treatment preferences. We also assessed the impact of the 2 most commonly proposed methods for improving surrogate accuracy.
METHODS

ASSESSMENT OF SURROGATES' PREDICTIVE ACCURACY
A comprehensive literature search was conducted using PubMed, the Cochrane Library, and manuscript references for studies published in English between 1966 and 2005 that report quantitative data on how accurately surrogates predict patients' treatment choices (no qualifying manuscripts were found in the Cochrane Library; information on search terms and results is available from the corresponding author).
Thesearchidentified21studies. Four studies that used the same data from the same sample population as an included study were excluded, 5, 10, 12, 14 as was 1 study that did not provide data on the percentageofagreementbetweenpatientsandtheir surrogates.
11 Theremaining16studiespre-sented a total of 151 hypothetical scenarios to 2595 surrogate-patient pairs and collectively analyzed 19 526 paired patientsurrogate responses (Figure 1) .
The hypothetical scenarios used in the studies described the patients as being unable to make their own medical decisions. The patients were asked whether, in these scenarios, they would want to receive specified medical interventions. The patients' surrogates were then independently asked to predict what choices the patients would make in the same hypothetical scenarios. The specified interventions were directly necessary to save or sustain the patient's life in more than 90% of the 151 scenarios. The following quotation is 1 example of a hypothetical scenario:
You recently suffered a major stroke leaving you in a coma and unable to breathe without a machine. After a few months, the doctor determines that it is unlikely that you will come out of the coma. If your doctor had asked whether to try to revive you if your heart stopped beating in this situation, what would you have told the doctor to do? 26 The hypothetical scenarios offered patients and their surrogates the option of accepting or refusing the proposed intervention. Nine studies 7, 8, [16] [17] [18] [19] 21, 23, 25 assessed respondents' confidence in their choices using a Likert scale, which the study authors then collapsed into either "accept" or "refuse" the intervention. Seven studies 7, 9, 17, 18, 21, 23, 25 included uncertain as a response option, which the study authors categorized as acceptance of the intervention based on recommendations that physicians treat patients under conditions of uncertainty. 27 While this assumption may not be appropriate in all cases, the individual studies did not provide the data necessary to assess surrogates' accuracy with the "uncertain" responses excluded from the analysis.
ASSESSMENT OF METHODS TO IMPROVE SURROGATES' PREDICTIVE ACCURACY
When patients do not designate a surrogate while they are capacitated, most states appoint a next-of-kin surrogate for them. 2 To assess the accuracy of patientdesignated vs legally assigned surrogates, we compared the accuracy data in the 11 studies that asked patients to designate their own surrogates [7] [8] [9] 13, [15] [16] [17] [18] [19] 22, 25 with the accuracy data in the 5 studies that assigned patients' surrogates using the relevant state's legal hierarchy. 6, 20, 21, 23, 24 To improve surrogate accuracy, many authors recommend that patients discuss their values and treatment preferences with family members or other potential surrogate decision makers. 15, 19, 21 Two of the eligible studies 12, 25 were designed to assess the effect of such discussions on surrogate accuracy. One of these studies 12 was excluded from the original analysis because it reported data from an included sample population but was used in this comparison because it explicitly assessed the impact of prior discussions on surrogate accuracy. No data were considered twice.
STATISTICAL ANALYSIS
Meta-analytic techniques were used to combine results across studies. The ␤-binomial model was used to estimate the overall percentage of agreement and the agreement within each study. For models assessing differences across health states and interventions, a randomeffects grouped logit model was used. The model is essentially a generalized linear model from the binomial family with a logit link, and a random effect is included for each study.
A Bayesian approach was used for both the random-effects and the ␤-binomial models. The software used in the study was WinBugs, version 2.0.1 (Medical Research Council Biostatistics Unit, Cambridge, England), which implements a Markov Chain Monte Carlo estimation procedure. The estimates provided are means from the posterior distributions of parameters and 95% credible intervals (CIs) are the 2.5th and 97.5th quantiles of the posterior distributions. Uninformative priors were used. We also considered main effects for both health state and intervention in the regression model, but because of sparseness, these results are not included or discussed.
Sensitivity analyses were conducted to determine the influence of individual studies on parameter estimates. Four reanalyses, each of which excluded 1 study from the analysis, were performed. The 4 studies chosen were selected because they had large sample sizes or a large number of scenarios and would therefore be most likely to influence results. A parameter estimate was considered to have been sensitive to a study if the parameter estimate when the study was excluded was not within the 95% CI of the estimate when the study was included.
RESULTS
The 16 studies that were included varied widely in both the number of surrogate-patient pairs sampled (range, 22 22 -1226 15 ) and the number of scenarios (range, 1 15 -30 25 ). 7 outpatients from hospital practices, 21 a convenience sample of patients with chronic disease, 16 and women older than 69 years. 25 Fifteen of the 16 studies focused on standard clinical care; the remaining study 8 
Overall, surrogates predicted patients'treatmentpreferenceswith68% accuracy (95% CI, 63-72). Figure 2 shows the distribution of surrogate accuracy percentages for the individual scenarios. We also assessed surrogate accuracy as a function of the patient's health state in the individual scenarios ( Table 1) and as a function of the proposed intervention ( Table 2) . Surrogates appear to be most accurate in scenarios involving the patient's current health (79%; 95% CI, 74-83) and in scenarios involving antibiotics (72%; 95% CI, 66-77). Surrogates appear to be least accurate inscenariosinvolvingdementia(58%; 95% CI, 52-64) and in scenarios involving stroke (58%; 95% CI, 52-64).
Twelve studies assessed the type of error surrogates make when they misjudge patients' treatment preferences: Three studies found that surrogates tend to err by providing interventions that the patient does not want 13, 19, 23 ; 1 study found that surrogates tend to err by withholding interventions that the patient does want 7 ; and 8 studies found mixed results or no consistent trend in surrogates' mistakes. 6, 8, 9, 16, 17, 20, 21, 24 It has been suggested that surrogates' projection of their own values onto patients may affect their ability to predict patients' choices. 28 However, the only study to address this concern concluded that in the absence of explicit prior instructions, projection may assist surrogates in predicting patients' preferences. 5 In 11 studies, reporting a total of 108 scenarios, patients designated their own surrogates. In 5 studies, reporting a total of 43 scenarios, investigators assigned the patients' surrogates using the relevant state's Table 3 ). Surrogates' relationship to the patient (eg, sibling, spouse, or child) was not significantly correlated with surrogates' predictive accuracy in the 4 studies that assessed this variable. [19] [20] [21] [22] Four additional studies confirmed that surrogates predict patients' preferences more accurately than do physicians. 6, 7, 17, 23 Two studies assessed whether discussion of patients' treatment preferences improves surrogate accuracy. The first study, 12 involving 9 health states and 315 surrogatepatient pairs, found no significant effect. The second study, 25 involving 30 scenarios and 60 surrogatepatient pairs, found a slight, but statistically significant worsening of surrogate accuracy after discussion of the patient's preferences ( Table 4) .
In general, sensitivity analyses showed little effects on parameter estimates when a given study was removed. However, the study by Smucker et al 18 was an exception for the analyses by health state only. For some of the health states, the agreement estimate changed when Smucker and colleagues' study was removed, suggesting that its agreement estimates for these health states differed from those of the other studies and that its sample size (n=401) and number of scenarios (n=27) were sufficiently large to have an effect on the parameter estimates (information on sensitivity analyses is available from the corresponding author).
COMMENT
Making end-of-life treatment decisions for patients who have lost the capacity to make their own decisions poses one of the most difficult ethical challenges in clinical medicine. In an attempt to extend patient autonomy, current practice is to rely on surrogates and to instruct them to attempt to make the decision that the patient would have made if he or she were capacitated. Despite widespread acceptance of this practice, the present analysis reveals that patientdesignated and next-of-kin surrogates fail to predict patients' end-oflife treatment preferences accurately in one third of all cases.
The present findings also reveal that the 2 most widely endorsed methods for improving surrogate accuracy are ineffective. Specifically, patient designation of surrogates does not appear to improve surrogate accuracy. 29, 30 Also, the 2 controlled studies that were designed to assess the impact of prior discussions of patients' treatment preferences found that these discussions do not improve surrogate accuracy. These findings are consistent with 3 other studies that found unclear impact of prior discussions on surrogate accuracy 8,9,15 and contradict 2 other studies that report that prior discussions increase surrogate accuracy. 20, 21 However, none of these 5 studies was controlled, and all of them relied on patient reports of whether a prior discussion had taken place. Therefore, taken together, available data suggest prior discussions of patient preferences do not improve surrogate accuracy.
The present data on surrogates' predictive accuracy are based on responses to hypothetical scenarios. It is unclear what impact the use of hypothetical scenarios has on surrogates' predictive accuracy. The data suggest that surrogates are most accurate in situations involving the patient's current health, suggesting that surrogates' predictions may be more accurate in real life than in response to hypothetical scenarios. Conversely, however, the stress, sorrow, and uncertainty that accompany caring for loved ones at the end of life may reduce surrogates' predictive accuracy in practice compared with the present findings.
The present findings call into question the ability of surrogates to predict patients' treatment preferences. However, they also reveal that surrogates are more accurate than physicians at predicting patients' treatment preferences. Therefore, in the absence of alternative methods, current reliance on surrogates may be defended as the best available method for implementing the substituted judgment standard. Future studies should consider whether there are other ways to improve surrogate accuracy. They should also investigate alternative methods to make treatment decisions for incapacitated patients and evaluate whether these methods more accurately predict patients' preferences. Finally, future studies should assess the impact of relying on surrogates vs alternative methods and determine whether patients or their families prefer one method over the other. Our analysis has 5 limitations. First, assessing agreement using the statistic was not possible given the included studies' presentation of data. However, we share skepticism expressed elsewhere regarding the appropriateness of the statistic for measuring surrogates' predictive accuracy. 21 Second, some studies classified "uncertain" responses from patients and surrogates as acceptance of the intervention in question, which may have influenced the results. Third, many of the scenarios did not provide possibly relevant data, such as the patient's chances of reaching the described postintervention health state. While these abbreviated descriptions may mimic clinical uncertainty, they may have led patients and surrogates to interpret the same scenarios in different ways. Fourth, the existing literature focuses primarily on surrogates' ability to predict patients' preferences for lifesaving interventions. The results may not reflect surrogates' ability to predict patients' preferences for nonlifesaving interventions. Fifth, hypothetical scenarios were used to assess surrogate accuracy. While surrogates may perform differently in actual cases compared with hypothetical scenarios, it is impossible to measure surrogate accuracy in actual cases because it is not possible to know the preferences of patients when they are incapacitated.
CONCLUSIONS
On average, patient-designated and next-of-kin surrogates incorrectly predict patients' end-of-life treatment preferences in one third of cases. Also, it appears that the 2 most commonly endorsed methods for improving surrogate accuracy-patient designation of a surrogate and prior discussion of treatment preferences with surrogates-are not effective. Assuming one goal of surrogate decision making is to predict what decision the patient would have made, future studies should attempt to identify methods to improve surrogate accuracy. They also should consider novel mechanisms to predict incapacitated patients' end-of-life treatment preferences. Alternatively, our data could imply that it is time to place less emphasis on predicting patients' treatment preferences accurately and that we should begin to assess whether patients and their families prefer to rely on surrogates, even when surrogates fail to predict patients' treatment preferences accurately. Finally, we should try to evaluate the impact that various methods of making treatment decisions has on surrogates, families, and loved ones.
